What is the recommended tapering regimen for a patient taking 20 mg of prednisone (corticosteroid) per day for 6 months?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Tapering Protocol for 20 mg Daily Dose After 6 Months of Treatment

For a patient who has been taking 20 mg of prednisone daily for 6 months, the optimal tapering schedule involves gradually reducing the dose to 10 mg/day within 4-8 weeks, then reducing by 2.5 mg every 2 weeks until reaching 5 mg/day, followed by a slower taper of 1 mg every 2-4 weeks until discontinuation. 1

Initial Tapering Phase (20 mg to 10 mg)

  • Reduce prednisone by 5 mg every 1-2 weeks until reaching 10 mg/day 2, 1
  • For example:
    • Weeks 1-2: 15 mg/day
    • Weeks 3-4: 10 mg/day

Intermediate Tapering Phase (10 mg to 5 mg)

  • Once at 10 mg/day, slow the taper to 2.5 mg decrements every 2 weeks 1, 3
  • For example:
    • Weeks 5-6: 7.5 mg/day
    • Weeks 7-8: 5 mg/day

Final Tapering Phase (Below 5 mg)

  • At 5 mg/day, further slow the taper to 1 mg decrements every 2-4 weeks until complete discontinuation 2, 1
  • For example:
    • Weeks 9-12: 4 mg/day
    • Weeks 13-16: 3 mg/day
    • Weeks 17-20: 2 mg/day
    • Weeks 21-24: 1 mg/day
    • Week 25: Discontinue

Rationale and Evidence

This tapering schedule is designed to minimize the risk of adrenal insufficiency while gradually withdrawing corticosteroid therapy. After 6 months of continuous prednisone at 20 mg/day, the hypothalamic-pituitary-adrenal (HPA) axis is likely suppressed, requiring a careful taper 4.

The FDA drug label for prednisone emphasizes that "if after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly" 4. This is particularly important after 6 months of therapy, as abrupt withdrawal could lead to adrenal crisis.

Special Considerations

Monitoring During Tapering

  • Watch for signs of disease relapse during tapering, which may necessitate temporarily returning to a higher dose 3
  • Monitor for symptoms of adrenal insufficiency (fatigue, weakness, nausea, hypotension) 5
  • Consider morning cortisol levels if symptoms of adrenal insufficiency develop 1

Alternative Approaches

  • For patients with severe steroid-related side effects, consider a more aggressive taper with close monitoring 2
  • For patients at high risk of disease relapse, consider a slower taper, particularly in the final phase 1, 3
  • For patients with significant night symptoms, consider split dosing rather than increasing the total daily dose when on low doses (<5 mg daily) 3

Common Pitfalls to Avoid

  • Tapering too quickly, which may precipitate disease flare or adrenal insufficiency 1
  • Failing to monitor for steroid-related side effects during the tapering process 2
  • Not providing patients with clear instructions about the tapering schedule 5
  • Abrupt discontinuation of therapy, which can lead to adrenal crisis 4

Disease-Specific Considerations

If the prednisone was prescribed for a specific condition, the tapering schedule might need adjustment:

  • For autoimmune hepatitis: Once at 20 mg/day, taper by 5 mg every week until reaching 10 mg/day, then by 2.5 mg/week until 5 mg/day is reached 2
  • For inflammatory myopathies: Taper by 10 mg every 2 weeks until reaching 30 mg/day, then by 5 mg every 2 weeks until reaching 20 mg/day, then by 2.5 mg every 2 weeks until completed 2
  • For bullous pemphigoid: Aim to reach minimal therapy (prednisone 0.1 mg/kg/day) within 4-6 months of initiation of treatment 2

This tapering protocol balances the need to minimize the risk of disease relapse while reducing the likelihood of steroid-related adverse effects and adrenal insufficiency.

References

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Systemic Corticosteroid Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Corticosteroid Tapering for Dermatologic Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.